Company page

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. is a public company listed under the ticker HALO, operating in the American market. With a market capitalization of approximately $9.72 billion, Halozyme focuses on developing and commercializing innovative therapies for various medical conditions. The company is known for its proprietary enzyme technology that enhances the delivery of biologic therapies.